| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 40 | 2022 | 3300 | 5.830 |
Why?
|
| Bone Marrow | 28 | 2022 | 2914 | 5.580 |
Why?
|
| Body Composition | 47 | 2024 | 2419 | 4.950 |
Why?
|
| Bone Density | 50 | 2023 | 3534 | 4.470 |
Why?
|
| Tomography, X-Ray Computed | 67 | 2024 | 20509 | 2.980 |
Why?
|
| Obesity | 54 | 2024 | 12919 | 2.950 |
Why?
|
| Gastrectomy | 18 | 2024 | 679 | 2.790 |
Why?
|
| Abdominal Fat | 8 | 2020 | 223 | 2.710 |
Why?
|
| Anorexia Nervosa | 20 | 2022 | 1361 | 2.670 |
Why?
|
| Radius | 10 | 2023 | 440 | 2.650 |
Why?
|
| Bone Neoplasms | 17 | 2023 | 2531 | 2.620 |
Why?
|
| Human Growth Hormone | 14 | 2022 | 638 | 2.190 |
Why?
|
| Magnetic Resonance Imaging | 79 | 2023 | 36286 | 2.180 |
Why?
|
| Bone and Bones | 17 | 2023 | 2560 | 2.130 |
Why?
|
| Adipose Tissue, Brown | 9 | 2019 | 755 | 2.040 |
Why?
|
| Absorptiometry, Photon | 28 | 2023 | 1736 | 2.000 |
Why?
|
| Arthrography | 7 | 2021 | 149 | 1.940 |
Why?
|
| Fluorodeoxyglucose F18 | 18 | 2022 | 2007 | 1.910 |
Why?
|
| Awards and Prizes | 3 | 2023 | 359 | 1.840 |
Why?
|
| Intra-Abdominal Fat | 11 | 2022 | 607 | 1.760 |
Why?
|
| Femoracetabular Impingement | 5 | 2021 | 178 | 1.600 |
Why?
|
| Adiposity | 19 | 2021 | 1858 | 1.580 |
Why?
|
| Obesity, Morbid | 11 | 2024 | 1287 | 1.560 |
Why?
|
| Joint Diseases | 7 | 2019 | 457 | 1.540 |
Why?
|
| Premenopause | 11 | 2016 | 1038 | 1.530 |
Why?
|
| Lumbar Vertebrae | 19 | 2023 | 1868 | 1.500 |
Why?
|
| Whole Body Imaging | 11 | 2022 | 278 | 1.330 |
Why?
|
| Obesity, Abdominal | 6 | 2017 | 374 | 1.320 |
Why?
|
| Osteoporosis | 4 | 2024 | 1601 | 1.290 |
Why?
|
| Fasting | 6 | 2023 | 1603 | 1.270 |
Why?
|
| Femur | 14 | 2023 | 1302 | 1.270 |
Why?
|
| Spinal Neoplasms | 4 | 2022 | 716 | 1.270 |
Why?
|
| Muscle, Skeletal | 15 | 2022 | 4924 | 1.250 |
Why?
|
| Radiology | 5 | 2023 | 2102 | 1.250 |
Why?
|
| Fractures, Bone | 6 | 2023 | 2041 | 1.240 |
Why?
|
| Hip Joint | 8 | 2021 | 1006 | 1.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2016 | 3765 | 1.160 |
Why?
|
| Neurofibromatosis 1 | 11 | 2022 | 560 | 1.120 |
Why?
|
| Young Adult | 85 | 2024 | 58748 | 1.100 |
Why?
|
| Sarcopenia | 2 | 2022 | 372 | 1.090 |
Why?
|
| Insulin-Like Growth Factor I | 16 | 2023 | 1928 | 1.080 |
Why?
|
| Humans | 274 | 2024 | 760613 | 1.080 |
Why?
|
| Femur Neck | 2 | 2021 | 311 | 1.070 |
Why?
|
| Adult | 163 | 2024 | 220007 | 1.070 |
Why?
|
| Cartilage Diseases | 5 | 2019 | 156 | 1.060 |
Why?
|
| Female | 195 | 2024 | 391246 | 1.030 |
Why?
|
| Elbow Joint | 5 | 2022 | 356 | 1.020 |
Why?
|
| Ischium | 4 | 2014 | 27 | 1.010 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 2 | 2018 | 179 | 1.000 |
Why?
|
| Tibia | 12 | 2023 | 1065 | 0.990 |
Why?
|
| Overweight | 13 | 2024 | 2421 | 0.990 |
Why?
|
| Bone Diseases | 2 | 2019 | 418 | 0.970 |
Why?
|
| Adolescent | 83 | 2024 | 87809 | 0.960 |
Why?
|
| Wrist Injuries | 3 | 2023 | 214 | 0.930 |
Why?
|
| Arthroscopy | 9 | 2017 | 960 | 0.930 |
Why?
|
| Bariatric Surgery | 6 | 2024 | 1005 | 0.910 |
Why?
|
| Bone Cysts, Aneurysmal | 3 | 2022 | 70 | 0.910 |
Why?
|
| Lipid Metabolism | 7 | 2018 | 1902 | 0.890 |
Why?
|
| Cumulative Trauma Disorders | 3 | 2019 | 148 | 0.880 |
Why?
|
| Hip Injuries | 2 | 2014 | 78 | 0.870 |
Why?
|
| Middle Aged | 124 | 2024 | 220359 | 0.870 |
Why?
|
| Hip | 3 | 2014 | 251 | 0.860 |
Why?
|
| Musculoskeletal Diseases | 2 | 2019 | 595 | 0.860 |
Why?
|
| Insulin Resistance | 14 | 2024 | 3959 | 0.820 |
Why?
|
| Adrenal Cortex Hormones | 5 | 2022 | 1869 | 0.820 |
Why?
|
| Knee Joint | 6 | 2023 | 1663 | 0.820 |
Why?
|
| Male | 145 | 2024 | 359718 | 0.810 |
Why?
|
| Soft Tissue Neoplasms | 8 | 2019 | 1152 | 0.800 |
Why?
|
| Arthralgia | 5 | 2015 | 461 | 0.800 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2024 | 258 | 0.800 |
Why?
|
| Subcutaneous Fat, Abdominal | 3 | 2017 | 91 | 0.790 |
Why?
|
| Positron-Emission Tomography | 15 | 2022 | 6465 | 0.770 |
Why?
|
| Muscular Diseases | 4 | 2018 | 551 | 0.770 |
Why?
|
| Diagnostic Imaging | 4 | 2023 | 3527 | 0.760 |
Why?
|
| Neurofibromatoses | 6 | 2018 | 299 | 0.750 |
Why?
|
| Musculoskeletal System | 3 | 2019 | 181 | 0.750 |
Why?
|
| Gastric Bypass | 6 | 2024 | 826 | 0.750 |
Why?
|
| Radiopharmaceuticals | 11 | 2021 | 2634 | 0.730 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 2 | 2018 | 77 | 0.730 |
Why?
|
| Faculty | 1 | 2023 | 383 | 0.700 |
Why?
|
| Chordoma | 3 | 2020 | 346 | 0.690 |
Why?
|
| Opportunistic Infections | 1 | 2023 | 377 | 0.690 |
Why?
|
| Sarcoma | 4 | 2019 | 1786 | 0.670 |
Why?
|
| Tendons | 4 | 2022 | 552 | 0.670 |
Why?
|
| Tendon Injuries | 7 | 2019 | 327 | 0.670 |
Why?
|
| Multiple Myeloma | 5 | 2021 | 5131 | 0.660 |
Why?
|
| Liver | 8 | 2023 | 7510 | 0.660 |
Why?
|
| Injections, Intra-Articular | 6 | 2022 | 279 | 0.640 |
Why?
|
| Lipids | 7 | 2022 | 3336 | 0.640 |
Why?
|
| Acromegaly | 2 | 2020 | 306 | 0.620 |
Why?
|
| Osteoarthritis, Hip | 4 | 2021 | 406 | 0.620 |
Why?
|
| Gadolinium DTPA | 3 | 2020 | 823 | 0.600 |
Why?
|
| Lumbosacral Region | 2 | 2016 | 291 | 0.600 |
Why?
|
| Hemangiosarcoma | 1 | 2020 | 216 | 0.600 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 3 | 2018 | 68 | 0.600 |
Why?
|
| Sensitivity and Specificity | 25 | 2018 | 14661 | 0.600 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2017 | 20 | 0.590 |
Why?
|
| Radiography, Interventional | 5 | 2019 | 1112 | 0.590 |
Why?
|
| Injections | 1 | 2020 | 830 | 0.580 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2019 | 3340 | 0.570 |
Why?
|
| Retrospective Studies | 50 | 2024 | 80345 | 0.560 |
Why?
|
| Spinal Fractures | 5 | 2020 | 702 | 0.550 |
Why?
|
| Synovial Cyst | 1 | 2016 | 35 | 0.550 |
Why?
|
| Rupture | 7 | 2022 | 443 | 0.550 |
Why?
|
| Neurofibroma, Plexiform | 3 | 2022 | 66 | 0.550 |
Why?
|
| Aged | 68 | 2024 | 169143 | 0.540 |
Why?
|
| Collateral Ligaments | 2 | 2010 | 34 | 0.540 |
Why?
|
| Anesthetics, Local | 3 | 2019 | 1001 | 0.540 |
Why?
|
| Contrast Media | 11 | 2020 | 5305 | 0.530 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2024 | 936 | 0.530 |
Why?
|
| Growth Hormone | 3 | 2023 | 568 | 0.520 |
Why?
|
| Psoas Muscles | 1 | 2016 | 66 | 0.520 |
Why?
|
| Physicians, Women | 1 | 2021 | 495 | 0.500 |
Why?
|
| Calcitonin | 1 | 2016 | 330 | 0.500 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2015 | 50 | 0.500 |
Why?
|
| Oxytocin | 3 | 2024 | 401 | 0.490 |
Why?
|
| Zygapophyseal Joint | 1 | 2016 | 128 | 0.480 |
Why?
|
| Cardiovascular Diseases | 10 | 2022 | 15760 | 0.470 |
Why?
|
| Patient Positioning | 1 | 2017 | 327 | 0.470 |
Why?
|
| Bone Remodeling | 2 | 2016 | 580 | 0.450 |
Why?
|
| Faculty, Medical | 4 | 2023 | 1192 | 0.450 |
Why?
|
| Cortisone | 2 | 2024 | 87 | 0.440 |
Why?
|
| Physical Examination | 1 | 2019 | 1244 | 0.440 |
Why?
|
| Pericardium | 1 | 2018 | 675 | 0.440 |
Why?
|
| Shoulder Joint | 3 | 2017 | 732 | 0.440 |
Why?
|
| Fluoroscopy | 4 | 2019 | 946 | 0.430 |
Why?
|
| Adipocytes | 2 | 2017 | 1179 | 0.430 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 233 | 0.430 |
Why?
|
| Tomography, Emission-Computed | 3 | 2007 | 1121 | 0.430 |
Why?
|
| Nerve Sheath Neoplasms | 4 | 2022 | 167 | 0.430 |
Why?
|
| Cold Temperature | 3 | 2015 | 780 | 0.420 |
Why?
|
| Pelvis | 1 | 2017 | 743 | 0.420 |
Why?
|
| Femur Head | 3 | 2021 | 297 | 0.410 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2017 | 133 | 0.410 |
Why?
|
| Burnout, Professional | 1 | 2021 | 702 | 0.410 |
Why?
|
| Cartilage, Articular | 4 | 2005 | 1091 | 0.410 |
Why?
|
| Mentors | 3 | 2023 | 661 | 0.400 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2016 | 409 | 0.400 |
Why?
|
| Neurilemmoma | 5 | 2018 | 523 | 0.400 |
Why?
|
| Estrone | 2 | 2023 | 232 | 0.400 |
Why?
|
| Chondroma | 1 | 2012 | 53 | 0.400 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1535 | 0.400 |
Why?
|
| Ultrasonography, Interventional | 2 | 2018 | 1501 | 0.400 |
Why?
|
| Reproducibility of Results | 21 | 2016 | 20080 | 0.390 |
Why?
|
| Protons | 3 | 2015 | 1114 | 0.390 |
Why?
|
| Radiography | 7 | 2023 | 6965 | 0.380 |
Why?
|
| Steroids | 1 | 2016 | 928 | 0.380 |
Why?
|
| Methionine | 2 | 2018 | 569 | 0.380 |
Why?
|
| Sex Characteristics | 3 | 2018 | 2629 | 0.380 |
Why?
|
| Abdomen | 1 | 2017 | 1130 | 0.380 |
Why?
|
| Soft Tissue Injuries | 1 | 2013 | 172 | 0.370 |
Why?
|
| Caregivers | 1 | 2023 | 2224 | 0.370 |
Why?
|
| Neck | 2 | 2016 | 731 | 0.360 |
Why?
|
| Diagnosis, Differential | 14 | 2021 | 12968 | 0.360 |
Why?
|
| Adiponectin | 4 | 2015 | 1114 | 0.360 |
Why?
|
| Curriculum | 1 | 2024 | 3718 | 0.360 |
Why?
|
| Neurofibromatosis 2 | 5 | 2016 | 385 | 0.360 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2012 | 1652 | 0.350 |
Why?
|
| Hydrocortisone | 4 | 2024 | 1803 | 0.350 |
Why?
|
| Spine | 4 | 2023 | 1111 | 0.350 |
Why?
|
| Amenorrhea | 3 | 2021 | 480 | 0.340 |
Why?
|
| Regression Analysis | 8 | 2016 | 6359 | 0.340 |
Why?
|
| Pain | 4 | 2019 | 5066 | 0.340 |
Why?
|
| Aged, 80 and over | 27 | 2020 | 58980 | 0.340 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 3202 | 0.340 |
Why?
|
| Triglycerides | 4 | 2014 | 2476 | 0.340 |
Why?
|
| Prospective Studies | 19 | 2023 | 54306 | 0.330 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2021 | 9278 | 0.330 |
Why?
|
| Acetabulum | 2 | 2021 | 541 | 0.330 |
Why?
|
| Bone Density Conservation Agents | 1 | 2016 | 796 | 0.330 |
Why?
|
| Mechanical Phenomena | 1 | 2010 | 140 | 0.330 |
Why?
|
| Anthropometry | 3 | 2013 | 1348 | 0.320 |
Why?
|
| Growth Hormone-Releasing Hormone | 2 | 2009 | 128 | 0.320 |
Why?
|
| Subcutaneous Fat | 5 | 2016 | 393 | 0.320 |
Why?
|
| Progesterone | 1 | 2013 | 742 | 0.320 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 377 | 0.310 |
Why?
|
| Thoracic Vertebrae | 2 | 2016 | 597 | 0.310 |
Why?
|
| Body Mass Index | 14 | 2022 | 12914 | 0.310 |
Why?
|
| Estrogens | 3 | 2021 | 1520 | 0.310 |
Why?
|
| Arthritis, Infectious | 1 | 2012 | 345 | 0.310 |
Why?
|
| Sacrum | 2 | 2023 | 277 | 0.310 |
Why?
|
| Trabecular Meshwork | 1 | 2008 | 100 | 0.300 |
Why?
|
| Giant Cell Tumor of Bone | 2 | 2022 | 117 | 0.300 |
Why?
|
| Tendinopathy | 3 | 2017 | 173 | 0.300 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2007 | 60 | 0.290 |
Why?
|
| Fibrosarcoma | 2 | 2023 | 308 | 0.290 |
Why?
|
| Cross-Sectional Studies | 21 | 2022 | 25941 | 0.290 |
Why?
|
| Extremities | 4 | 2018 | 867 | 0.280 |
Why?
|
| Case-Control Studies | 16 | 2020 | 22052 | 0.280 |
Why?
|
| Hominidae | 2 | 2018 | 68 | 0.280 |
Why?
|
| Sacroiliac Joint | 1 | 2006 | 57 | 0.270 |
Why?
|
| Knee Injuries | 4 | 2018 | 489 | 0.270 |
Why?
|
| Endocrine System Diseases | 1 | 2008 | 250 | 0.270 |
Why?
|
| Fractures, Compression | 1 | 2008 | 129 | 0.270 |
Why?
|
| Hormones | 3 | 2016 | 867 | 0.260 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2009 | 542 | 0.260 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 2061 | 0.260 |
Why?
|
| Placebos | 3 | 2017 | 1668 | 0.260 |
Why?
|
| Prognosis | 10 | 2023 | 29661 | 0.260 |
Why?
|
| Arginine | 1 | 2009 | 934 | 0.250 |
Why?
|
| Neoplasms | 4 | 2019 | 22075 | 0.250 |
Why?
|
| Range of Motion, Articular | 5 | 2023 | 1583 | 0.250 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2006 | 152 | 0.250 |
Why?
|
| Administration, Intranasal | 2 | 2024 | 471 | 0.250 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2010 | 470 | 0.250 |
Why?
|
| Metformin | 1 | 2013 | 912 | 0.250 |
Why?
|
| Scoliosis | 1 | 2011 | 735 | 0.240 |
Why?
|
| Neurofibroma | 2 | 2022 | 94 | 0.240 |
Why?
|
| Program Evaluation | 2 | 2024 | 2493 | 0.240 |
Why?
|
| Weight Loss | 7 | 2024 | 2684 | 0.240 |
Why?
|
| Fractures, Spontaneous | 2 | 2017 | 231 | 0.240 |
Why?
|
| Ligaments, Articular | 2 | 2019 | 300 | 0.240 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 2660 | 0.230 |
Why?
|
| Sports | 1 | 2010 | 700 | 0.230 |
Why?
|
| Longitudinal Studies | 7 | 2023 | 14494 | 0.230 |
Why?
|
| Gene Fusion | 3 | 2021 | 354 | 0.220 |
Why?
|
| Bacterial Infections | 1 | 2012 | 1403 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7475 | 0.220 |
Why?
|
| Myostatin | 1 | 2024 | 127 | 0.220 |
Why?
|
| Radiation Dosage | 4 | 2019 | 1957 | 0.220 |
Why?
|
| Fats | 2 | 2016 | 99 | 0.210 |
Why?
|
| Nerve Compression Syndromes | 2 | 2015 | 160 | 0.210 |
Why?
|
| Finite Element Analysis | 4 | 2019 | 428 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 12289 | 0.210 |
Why?
|
| Buttocks | 2 | 2020 | 111 | 0.210 |
Why?
|
| Osteosarcoma | 3 | 2018 | 897 | 0.210 |
Why?
|
| Societies, Medical | 3 | 2019 | 3905 | 0.200 |
Why?
|
| Appetite | 2 | 2022 | 247 | 0.200 |
Why?
|
| Double-Blind Method | 7 | 2024 | 12427 | 0.200 |
Why?
|
| Foot | 2 | 2018 | 573 | 0.200 |
Why?
|
| Osteoblastoma | 1 | 2022 | 24 | 0.200 |
Why?
|
| Treatment Outcome | 18 | 2024 | 64981 | 0.200 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 13262 | 0.200 |
Why?
|
| Diaphyses | 2 | 2019 | 65 | 0.200 |
Why?
|
| Athletic Injuries | 2 | 2018 | 1209 | 0.190 |
Why?
|
| Glucose | 3 | 2023 | 4350 | 0.190 |
Why?
|
| Prevalence | 8 | 2020 | 15686 | 0.190 |
Why?
|
| Osteoblasts | 2 | 2017 | 1142 | 0.190 |
Why?
|
| Testosterone | 5 | 2023 | 2470 | 0.190 |
Why?
|
| Membrane Proteins | 4 | 2015 | 7850 | 0.190 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 2 | 2012 | 138 | 0.190 |
Why?
|
| Risk Assessment | 9 | 2018 | 24102 | 0.190 |
Why?
|
| Bone Cysts | 1 | 2021 | 48 | 0.190 |
Why?
|
| Neoplasm Staging | 4 | 2021 | 11152 | 0.190 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2016 | 546 | 0.190 |
Why?
|
| Langerhans Cells | 1 | 2021 | 171 | 0.180 |
Why?
|
| Career Mobility | 1 | 2023 | 258 | 0.180 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2023 | 263 | 0.180 |
Why?
|
| Traction | 1 | 2021 | 106 | 0.180 |
Why?
|
| Pituitary Neoplasms | 2 | 2020 | 1313 | 0.180 |
Why?
|
| Risk Factors | 18 | 2022 | 74333 | 0.180 |
Why?
|
| Ghrelin | 1 | 2022 | 252 | 0.180 |
Why?
|
| Torsion Abnormality | 1 | 2021 | 91 | 0.180 |
Why?
|
| Child | 18 | 2023 | 79799 | 0.180 |
Why?
|
| Muscular Atrophy | 2 | 2020 | 331 | 0.180 |
Why?
|
| Chondroblastoma | 1 | 2020 | 48 | 0.180 |
Why?
|
| Chondrosarcoma | 1 | 2023 | 296 | 0.180 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 3149 | 0.170 |
Why?
|
| Tennis Elbow | 1 | 1999 | 16 | 0.170 |
Why?
|
| Cell Dedifferentiation | 1 | 2020 | 122 | 0.170 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2021 | 169 | 0.170 |
Why?
|
| Hypertension | 2 | 2020 | 8595 | 0.170 |
Why?
|
| Shoulder Impingement Syndrome | 1 | 1999 | 35 | 0.170 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2021 | 210 | 0.170 |
Why?
|
| Receptors, Somatostatin | 1 | 2020 | 136 | 0.170 |
Why?
|
| Ankle Joint | 1 | 2023 | 435 | 0.160 |
Why?
|
| Berlin | 1 | 2018 | 23 | 0.160 |
Why?
|
| Humerus | 1 | 2021 | 269 | 0.160 |
Why?
|
| Follow-Up Studies | 8 | 2022 | 39262 | 0.160 |
Why?
|
| Receptors, Calcitriol | 1 | 2021 | 359 | 0.160 |
Why?
|
| Synovitis | 1 | 2000 | 215 | 0.160 |
Why?
|
| NFATC Transcription Factors | 1 | 2021 | 381 | 0.160 |
Why?
|
| Calcaneus | 3 | 2018 | 142 | 0.160 |
Why?
|
| Injections, Intralesional | 2 | 2016 | 278 | 0.160 |
Why?
|
| Boston | 7 | 2020 | 9278 | 0.160 |
Why?
|
| Tarsal Bones | 2 | 2018 | 70 | 0.160 |
Why?
|
| Fibula | 1 | 2021 | 265 | 0.160 |
Why?
|
| Sex Factors | 4 | 2018 | 10546 | 0.160 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2021 | 224 | 0.160 |
Why?
|
| Diet, Protein-Restricted | 1 | 2018 | 73 | 0.160 |
Why?
|
| Pandemics | 4 | 2022 | 8623 | 0.150 |
Why?
|
| Femur Head Necrosis | 1 | 2019 | 132 | 0.150 |
Why?
|
| Fossils | 1 | 2018 | 75 | 0.150 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2021 | 454 | 0.150 |
Why?
|
| Tumor Burden | 5 | 2018 | 1895 | 0.150 |
Why?
|
| Fractures, Stress | 1 | 2020 | 200 | 0.150 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 1999 | 122 | 0.150 |
Why?
|
| Neural Conduction | 1 | 1999 | 441 | 0.150 |
Why?
|
| Water | 2 | 2018 | 1407 | 0.150 |
Why?
|
| Time Factors | 7 | 2024 | 40139 | 0.150 |
Why?
|
| Ergolines | 1 | 2017 | 57 | 0.150 |
Why?
|
| Endometrium | 1 | 2000 | 403 | 0.150 |
Why?
|
| Predictive Value of Tests | 8 | 2018 | 15286 | 0.150 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 2557 | 0.150 |
Why?
|
| Shoulder | 1 | 1999 | 299 | 0.150 |
Why?
|
| Femoral Neoplasms | 1 | 2017 | 81 | 0.150 |
Why?
|
| Pectoralis Muscles | 1 | 2018 | 85 | 0.150 |
Why?
|
| Muscles | 2 | 2014 | 1581 | 0.150 |
Why?
|
| Osteocalcin | 2 | 2017 | 274 | 0.140 |
Why?
|
| Pituitary Diseases | 2 | 2016 | 135 | 0.140 |
Why?
|
| Thorax | 1 | 2020 | 553 | 0.140 |
Why?
|
| Postoperative Period | 3 | 2020 | 1818 | 0.140 |
Why?
|
| Research Personnel | 1 | 2022 | 582 | 0.140 |
Why?
|
| Central Cord Syndrome | 1 | 2016 | 5 | 0.140 |
Why?
|
| Leg | 3 | 2011 | 1091 | 0.140 |
Why?
|
| Baseball | 2 | 2008 | 95 | 0.140 |
Why?
|
| Spondylosis | 1 | 2017 | 85 | 0.140 |
Why?
|
| Radiation Protection | 2 | 2017 | 425 | 0.140 |
Why?
|
| Disease Progression | 5 | 2021 | 13505 | 0.140 |
Why?
|
| Social Behavior | 1 | 2023 | 1131 | 0.140 |
Why?
|
| Fibroma | 1 | 2018 | 190 | 0.140 |
Why?
|
| Lipodystrophy | 1 | 2017 | 148 | 0.140 |
Why?
|
| Germany | 1 | 2018 | 873 | 0.130 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 282 | 0.130 |
Why?
|
| Brain | 2 | 2021 | 26951 | 0.130 |
Why?
|
| Liposarcoma | 1 | 2019 | 283 | 0.130 |
Why?
|
| Calcinosis | 2 | 2016 | 1476 | 0.130 |
Why?
|
| Receptors, GABA | 1 | 2018 | 305 | 0.130 |
Why?
|
| Gene Expression | 2 | 2021 | 7587 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 415 | 0.130 |
Why?
|
| Receptors, Somatotropin | 1 | 2016 | 58 | 0.130 |
Why?
|
| Observer Variation | 4 | 2015 | 2601 | 0.130 |
Why?
|
| Sarcoma, Synovial | 1 | 2017 | 151 | 0.130 |
Why?
|
| Energy Metabolism | 3 | 2024 | 2869 | 0.130 |
Why?
|
| Food | 1 | 2021 | 771 | 0.130 |
Why?
|
| Tarsal Joints | 1 | 2015 | 32 | 0.130 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2016 | 240 | 0.130 |
Why?
|
| Lectins | 1 | 2017 | 484 | 0.130 |
Why?
|
| Skin Neoplasms | 4 | 2018 | 5799 | 0.130 |
Why?
|
| Somatostatin | 1 | 2017 | 447 | 0.130 |
Why?
|
| Foot Joints | 1 | 2015 | 35 | 0.130 |
Why?
|
| Peptides, Cyclic | 1 | 2017 | 392 | 0.130 |
Why?
|
| New York | 1 | 2018 | 875 | 0.130 |
Why?
|
| Pilot Projects | 3 | 2024 | 8556 | 0.130 |
Why?
|
| Cell Size | 1 | 2017 | 624 | 0.120 |
Why?
|
| Blood Glucose | 5 | 2017 | 6379 | 0.120 |
Why?
|
| Peer Group | 1 | 2020 | 674 | 0.120 |
Why?
|
| Starvation | 1 | 2015 | 140 | 0.120 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 393 | 0.120 |
Why?
|
| Cardiovascular System | 2 | 2013 | 850 | 0.120 |
Why?
|
| Biopsy | 5 | 2018 | 6771 | 0.120 |
Why?
|
| Cushing Syndrome | 1 | 2016 | 241 | 0.120 |
Why?
|
| Perception | 1 | 2021 | 1195 | 0.120 |
Why?
|
| Health Status Disparities | 2 | 2017 | 1829 | 0.120 |
Why?
|
| Up-Regulation | 3 | 2021 | 4122 | 0.120 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2014 | 131 | 0.120 |
Why?
|
| Venous Insufficiency | 1 | 2016 | 111 | 0.120 |
Why?
|
| Epithelioid Cells | 1 | 2014 | 60 | 0.120 |
Why?
|
| Causality | 3 | 2016 | 1242 | 0.120 |
Why?
|
| Electromyography | 1 | 1999 | 1388 | 0.120 |
Why?
|
| Pain Measurement | 5 | 2018 | 3527 | 0.120 |
Why?
|
| Canada | 1 | 2019 | 2126 | 0.120 |
Why?
|
| Anorexia | 1 | 2014 | 154 | 0.120 |
Why?
|
| Minority Groups | 1 | 2021 | 1201 | 0.110 |
Why?
|
| Comorbidity | 5 | 2019 | 10553 | 0.110 |
Why?
|
| Iliotibial Band Syndrome | 1 | 2013 | 5 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2024 | 8950 | 0.110 |
Why?
|
| Femoral Neuropathy | 1 | 2013 | 7 | 0.110 |
Why?
|
| Osteoporotic Fractures | 1 | 2018 | 409 | 0.110 |
Why?
|
| C-Reactive Protein | 5 | 2015 | 3839 | 0.110 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2017 | 701 | 0.110 |
Why?
|
| Endocrine System | 1 | 2014 | 112 | 0.110 |
Why?
|
| Procollagen | 1 | 2014 | 188 | 0.110 |
Why?
|
| Bursa, Synovial | 1 | 2013 | 25 | 0.110 |
Why?
|
| Tenosynovitis | 1 | 2013 | 57 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2015 | 1406 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7408 | 0.110 |
Why?
|
| Cognition | 3 | 2016 | 6964 | 0.110 |
Why?
|
| Tongue | 1 | 2016 | 404 | 0.110 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 1842 | 0.110 |
Why?
|
| Ulna | 1 | 2014 | 134 | 0.110 |
Why?
|
| Angiofibroma | 1 | 2013 | 55 | 0.110 |
Why?
|
| Thinness | 1 | 2017 | 491 | 0.110 |
Why?
|
| Ligaments | 1 | 2013 | 127 | 0.110 |
Why?
|
| Respiratory System | 1 | 2016 | 557 | 0.110 |
Why?
|
| Sternoclavicular Joint | 1 | 2012 | 32 | 0.110 |
Why?
|
| Prednisone | 1 | 2017 | 1566 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2018 | 805 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 21029 | 0.100 |
Why?
|
| Nutrition Surveys | 1 | 2020 | 1725 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 3 | 2012 | 1067 | 0.100 |
Why?
|
| Bursitis | 1 | 2013 | 80 | 0.100 |
Why?
|
| Glucagon | 1 | 2014 | 532 | 0.100 |
Why?
|
| Atrophy | 2 | 2015 | 1626 | 0.100 |
Why?
|
| Outpatients | 1 | 2020 | 1607 | 0.100 |
Why?
|
| Estradiol | 3 | 2021 | 1932 | 0.100 |
Why?
|
| Myositis Ossificans | 1 | 2013 | 77 | 0.100 |
Why?
|
| Dyslipidemias | 1 | 2020 | 895 | 0.100 |
Why?
|
| Visual Perception | 1 | 2021 | 1374 | 0.100 |
Why?
|
| Apolipoproteins B | 1 | 2014 | 388 | 0.100 |
Why?
|
| S100 Proteins | 1 | 2012 | 218 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 12531 | 0.100 |
Why?
|
| Feasibility Studies | 2 | 2015 | 5201 | 0.100 |
Why?
|
| Leadership | 1 | 2021 | 1371 | 0.100 |
Why?
|
| Wrist Joint | 1 | 2014 | 265 | 0.100 |
Why?
|
| Patella | 1 | 2013 | 313 | 0.100 |
Why?
|
| Caloric Restriction | 1 | 2014 | 295 | 0.100 |
Why?
|
| Syndrome | 3 | 2018 | 3280 | 0.100 |
Why?
|
| Bone Marrow Cells | 2 | 2017 | 2414 | 0.100 |
Why?
|
| Military Personnel | 1 | 2020 | 1244 | 0.090 |
Why?
|
| Thermogenesis | 1 | 2015 | 468 | 0.090 |
Why?
|
| Cholesterol, HDL | 2 | 2015 | 1817 | 0.090 |
Why?
|
| ROC Curve | 3 | 2020 | 3568 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 2754 | 0.090 |
Why?
|
| Edema | 1 | 2014 | 770 | 0.090 |
Why?
|
| Vitamin D | 3 | 2013 | 3291 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 1 | 2000 | 2176 | 0.090 |
Why?
|
| Mitochondria | 2 | 2013 | 3601 | 0.090 |
Why?
|
| Iodide Peroxidase | 1 | 2012 | 294 | 0.090 |
Why?
|
| Suicidal Ideation | 1 | 2020 | 1425 | 0.090 |
Why?
|
| Triiodothyronine | 1 | 2012 | 493 | 0.090 |
Why?
|
| Waist Circumference | 2 | 2016 | 926 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1030 | 0.090 |
Why?
|
| Insulin | 5 | 2023 | 6596 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2018 | 1380 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1392 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2012 | 562 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 2299 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 869 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2018 | 2255 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2016 | 818 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2145 | 0.080 |
Why?
|
| Anxiety | 2 | 2024 | 4538 | 0.080 |
Why?
|
| Ankle Injuries | 1 | 2013 | 334 | 0.080 |
Why?
|
| Health Promotion | 1 | 2021 | 2207 | 0.080 |
Why?
|
| Skinfold Thickness | 1 | 2008 | 158 | 0.080 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2008 | 43 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 1296 | 0.080 |
Why?
|
| New England | 1 | 2012 | 1050 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 3696 | 0.080 |
Why?
|
| Metatarsalgia | 1 | 2008 | 3 | 0.080 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2011 | 268 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2022 | 15679 | 0.080 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 622 | 0.080 |
Why?
|
| Thyrotropin | 1 | 2012 | 832 | 0.080 |
Why?
|
| Thyroxine | 1 | 2012 | 667 | 0.080 |
Why?
|
| Patellar Dislocation | 1 | 2009 | 66 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2020 | 11070 | 0.070 |
Why?
|
| Body Fat Distribution | 1 | 2009 | 243 | 0.070 |
Why?
|
| Adenoma | 1 | 2018 | 2148 | 0.070 |
Why?
|
| Wound Healing | 1 | 2018 | 2788 | 0.070 |
Why?
|
| Athletes | 1 | 2015 | 1125 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2009 | 4046 | 0.070 |
Why?
|
| Memory | 2 | 2016 | 2179 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2017 | 4000 | 0.070 |
Why?
|
| Friction | 2 | 2018 | 59 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2014 | 1271 | 0.070 |
Why?
|
| Metatarsal Bones | 1 | 2008 | 111 | 0.070 |
Why?
|
| United States | 3 | 2024 | 72448 | 0.070 |
Why?
|
| Carbon Isotopes | 1 | 2007 | 459 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2011 | 698 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 4319 | 0.070 |
Why?
|
| Ossification, Heterotopic | 1 | 2009 | 235 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2014 | 989 | 0.070 |
Why?
|
| Rotation | 2 | 2023 | 514 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4611 | 0.070 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 1797 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2829 | 0.070 |
Why?
|
| Seasons | 1 | 2012 | 1522 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2018 | 3016 | 0.060 |
Why?
|
| Exercise | 2 | 2013 | 5787 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 1988 | 0.060 |
Why?
|
| Gene Rearrangement | 2 | 2021 | 1122 | 0.060 |
Why?
|
| Neutrophils | 1 | 2017 | 3767 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 2420 | 0.060 |
Why?
|
| Radiology Information Systems | 1 | 2009 | 528 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10185 | 0.060 |
Why?
|
| Mass Screening | 1 | 2020 | 5422 | 0.060 |
Why?
|
| Linear Models | 1 | 2014 | 5877 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2019 | 3426 | 0.060 |
Why?
|
| Reference Values | 3 | 2017 | 4925 | 0.060 |
Why?
|
| Weight-Bearing | 2 | 2017 | 518 | 0.060 |
Why?
|
| Algorithms | 2 | 2017 | 13982 | 0.060 |
Why?
|
| Gonadal Hormones | 1 | 2023 | 30 | 0.060 |
Why?
|
| Mice, Inbred C3H | 2 | 2015 | 915 | 0.060 |
Why?
|
| Waist-Hip Ratio | 2 | 2016 | 516 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3802 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 2 | 2016 | 1722 | 0.050 |
Why?
|
| Homeostasis | 2 | 2013 | 3306 | 0.050 |
Why?
|
| Ilium | 1 | 2023 | 154 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2011 | 1193 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2021 | 2505 | 0.050 |
Why?
|
| Leucine | 1 | 2023 | 547 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2014 | 8525 | 0.050 |
Why?
|
| Peptide YY | 1 | 2022 | 136 | 0.050 |
Why?
|
| Joint Instability | 1 | 2009 | 795 | 0.050 |
Why?
|
| Fibrosis | 2 | 2022 | 2042 | 0.050 |
Why?
|
| Child, Preschool | 5 | 2021 | 42056 | 0.050 |
Why?
|
| Periosteum | 1 | 2002 | 138 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2014 | 5132 | 0.050 |
Why?
|
| Quality of Life | 3 | 2022 | 13308 | 0.050 |
Why?
|
| Depression | 1 | 2020 | 8045 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 8055 | 0.040 |
Why?
|
| Scapula | 1 | 2002 | 173 | 0.040 |
Why?
|
| Ankle | 1 | 2023 | 350 | 0.040 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2020 | 49 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 6316 | 0.040 |
Why?
|
| Executive Function | 2 | 2021 | 1374 | 0.040 |
Why?
|
| Brachial Plexus Neuritis | 1 | 1999 | 20 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 380 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2001 | 296 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2013 | 1174 | 0.040 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2716 | 0.040 |
Why?
|
| Florida | 1 | 2020 | 430 | 0.040 |
Why?
|
| Models, Biological | 1 | 2015 | 9468 | 0.040 |
Why?
|
| Triamcinolone | 1 | 2019 | 68 | 0.040 |
Why?
|
| Statistics, Nonparametric | 3 | 2009 | 2852 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3617 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 22020 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 5890 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 555 | 0.040 |
Why?
|
| Cohort Studies | 5 | 2018 | 41337 | 0.040 |
Why?
|
| Transcription Factors | 4 | 2021 | 12102 | 0.040 |
Why?
|
| Neoplasm, Residual | 1 | 2002 | 1008 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 2000 | 524 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 368 | 0.030 |
Why?
|
| Ethiopia | 1 | 2018 | 462 | 0.030 |
Why?
|
| Energy Intake | 1 | 2024 | 2129 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2016 | 141 | 0.030 |
Why?
|
| Animals | 9 | 2022 | 167960 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2020 | 1599 | 0.030 |
Why?
|
| Pelvic Neoplasms | 1 | 2018 | 248 | 0.030 |
Why?
|
| Phenotype | 3 | 2020 | 16548 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 679 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2015 | 6796 | 0.030 |
Why?
|
| Iopamidol | 1 | 2016 | 186 | 0.030 |
Why?
|
| Cues | 1 | 2021 | 867 | 0.030 |
Why?
|
| Thoracic Neoplasms | 1 | 2018 | 266 | 0.030 |
Why?
|
| Kinetics | 1 | 2023 | 6377 | 0.030 |
Why?
|
| Adrenal Gland Diseases | 1 | 2016 | 141 | 0.030 |
Why?
|
| Laminectomy | 1 | 2016 | 224 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2016 | 5961 | 0.030 |
Why?
|
| Fracture Fixation | 1 | 2017 | 365 | 0.030 |
Why?
|
| Hallux | 1 | 2015 | 43 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 568 | 0.030 |
Why?
|
| Mucin-4 | 1 | 2014 | 33 | 0.030 |
Why?
|
| Lipolysis | 1 | 2016 | 211 | 0.030 |
Why?
|
| Fracture Healing | 1 | 2017 | 438 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 47 | 0.030 |
Why?
|
| Sclerosis | 1 | 2014 | 210 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2021 | 2913 | 0.030 |
Why?
|
| Inflammation | 1 | 2014 | 10755 | 0.030 |
Why?
|
| Incidence | 3 | 2022 | 21391 | 0.030 |
Why?
|
| Lipase | 1 | 2016 | 324 | 0.030 |
Why?
|
| Telomerase | 1 | 2019 | 747 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1635 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 538 | 0.030 |
Why?
|
| Hematoma | 1 | 2018 | 769 | 0.030 |
Why?
|
| Ideal Body Weight | 1 | 2012 | 27 | 0.030 |
Why?
|
| Leptin | 2 | 2012 | 1590 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2017 | 821 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13627 | 0.030 |
Why?
|
| Cholesterol | 2 | 2015 | 2924 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1229 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 1112 | 0.030 |
Why?
|
| Infant | 2 | 2021 | 36053 | 0.030 |
Why?
|
| Back | 1 | 2012 | 64 | 0.030 |
Why?
|
| Osteoclasts | 1 | 2016 | 712 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 1931 | 0.020 |
Why?
|
| Postural Balance | 1 | 2016 | 617 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2896 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 6538 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2414 | 0.020 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1214 | 0.020 |
Why?
|
| Equipment Design | 2 | 2011 | 3520 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2014 | 365 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2254 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 875 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2013 | 443 | 0.020 |
Why?
|
| Self Report | 1 | 2022 | 3711 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 2821 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2015 | 717 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1630 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2014 | 719 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2016 | 978 | 0.020 |
Why?
|
| Anesthetics | 1 | 2015 | 522 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2012 | 555 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 5782 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 2924 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2362 | 0.020 |
Why?
|
| Histones | 1 | 2020 | 2582 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2023 | 6218 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 4496 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 2512 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2012 | 459 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15840 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2015 | 2897 | 0.020 |
Why?
|
| X-Ray Intensifying Screens | 1 | 2008 | 32 | 0.020 |
Why?
|
| Accidental Falls | 1 | 2016 | 1056 | 0.020 |
Why?
|
| Forefoot, Human | 1 | 2008 | 31 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 2262 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 3618 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2012 | 1110 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2015 | 1804 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 346 | 0.020 |
Why?
|
| E-Selectin | 1 | 2009 | 576 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2016 | 2907 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1894 | 0.020 |
Why?
|
| Rotator Cuff | 1 | 2009 | 342 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5640 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 5795 | 0.020 |
Why?
|
| Cadaver | 1 | 2010 | 1345 | 0.020 |
Why?
|
| Mutation | 2 | 2020 | 29957 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 12957 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2009 | 1126 | 0.020 |
Why?
|
| Logistic Models | 1 | 2020 | 13312 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4902 | 0.020 |
Why?
|
| Hyalin | 1 | 2005 | 34 | 0.020 |
Why?
|
| Mice | 3 | 2017 | 81209 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 8158 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2019 | 8022 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 2018 | 2882 | 0.010 |
Why?
|
| Software | 1 | 2017 | 4419 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7022 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2016 | 4938 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16932 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12762 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2005 | 475 | 0.010 |
Why?
|
| Shoulder Dislocation | 1 | 2002 | 129 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2015 | 14374 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10442 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2009 | 3215 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17790 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3701 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2009 | 2881 | 0.010 |
Why?
|
| Aging | 1 | 2016 | 8652 | 0.010 |
Why?
|
| Massachusetts | 1 | 2009 | 8803 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 18413 | 0.010 |
Why?
|